Carmel Wroth
Carmel Wroth is a senior health editor for NPR's Science Desk, where she guides digital strategy for the health team and conceives and edits digital-first, enterprise stories and packages.
Formerly, she founded and managed Side Effects Public Media, a public radio collaborative covering public health in the Midwest. Wroth also served as an editor at Yoga Journal for five years.
-
In a controversial move, the vaccine advisory group reversed a recommendations for universal immunizing of newborns intended to protect them from a virus that attacks the liver. -
Millions of Americans face sharply rising costs for health care plans they bought through the Affordable Care Act marketplaces, unless Congress acts soon. Here's what's at stake for them. -
The group was chosen by Health Secretary Robert F. Kennedy Jr. amid controversy. It's changed guidance for for measles, mumps, rubella and chickenpox shots and deferred proposed changes to hepatitis B. -
The Make America Healthy Again commission is proposing more than 100 moves to address the root causes of childhood chronic disease. Critics say other Trump administration moves contradict the goals. -
Researchers and advocates have pushed back at what they consider inaccurate and stigmatizing comments made by the health secretary, and note the causes of autism are complex. -
Staffers began receiving termination notices this morning as part of a major restructuring at HHS. Some senior leadership are on their way out too. -
The influential US Preventive Services Task Force urged behavioral counseling for children and teens with very high BMI. Notably the group did not include Ozempic-like drugs in the recommendation. -
You might want to cancel that holiday party, and definitely dust off your face mask. Don't panic, but do step up your precautions. Here's how. -
What's the U.S. doing to watch out for the omicron variant? Here's the work underway and the challenges that experts say may slow down the country's efforts. -
Kids ages 5 to 11 will soon be able to get Pfizer's low-dose COVID vaccine. CDC director Rochelle Walensky agreed with a unanimous decision of a team of advisers that the benefits outweigh the risks.
